title: 5-AZA-2'-deoxycytidine in cancer immunotherapy: a mouse to man story.
authors.forename: Sandra
authors.initials: S
authors.lastname: Coral
authors.forename: Luca
authors.initials: L
authors.lastname: Sigalotti
authors.forename: Alessia
authors.initials: A
authors.lastname: Covre
authors.forename: Hugues J M
authors.initials: HJ
authors.lastname: Nicolay
authors.forename: Pier Giorgio
authors.initials: PG
authors.lastname: Natali
authors.forename: Michele
authors.initials: M
authors.lastname: Maio
mesh_terms: D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology; D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology*; D001374:Azacitidine / Q000031:analogs & derivatives* / Q000494:pharmacology; D000077209:Decitabine; D006801:Humans; D016219:Immunotherapy, Adoptive; D008545:Melanoma / Q000276:immunology / Q000628:therapy*; D051379:Mice; D023041:Xenograft Model Antitumor Assays
chemical_list: D000951:Antigens, Neoplasm; D000964:Antimetabolites, Antineoplastic; D000077209:Decitabine; D001374:Azacitidine